# Ciprofloxacin for the Prevention of Meningococcal Meningitis 2018

> **NCT03431675** · PHASE4 · WITHDRAWN · sponsor: **Epicentre**

## Conditions studied

- Meningitis, Meningococcal

## Interventions

- **DRUG:** Ciprofloxacin

## Key facts

- **NCT ID:** NCT03431675
- **Lead sponsor:** Epicentre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-03-01
- **Primary completion:** 2019-06-30
- **Final completion:** 2019-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No epidemic of Men C in 2019
- **Last updated:** 2019-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03431675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03431675, "Ciprofloxacin for the Prevention of Meningococcal Meningitis 2018". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03431675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*